Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea-Reference-Cited by-同舟云学术

Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea

Published:2015-06 Issue:3 Volume:24 Page:213-217
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Park Yeon Hee,Lee Su Jin,Jung Hyun Ae,Kim Sung Min,Kim Moon Jin,Kil Won Ho,Lee Jeong Eon,Nam Seok Jin,Ahn Jin Seok,Im Young-Hyuck

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference23 articles.

1. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival;Jemal;Cancer,2004

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. Breast cancer before age 40 years;Anders;Semin Oncol,2009

4. Breast cancer in young women: poor survival despite intensive treatment;Fredholm;PLoS One,2009

5. Young age: an independent risk factor for disease-free survival in women with operable breast cancer;Han;BMC Cancer,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile;Breast Cancer;2024-03-12

2. Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort;Cancers;2022-10-04

3. Comparing the Prognoses of Breast-Conserving Surgeries for Differently Aged Women with Early Stage Breast Cancer: Use of a Propensity Score Method;The Breast Journal;2022-04-23

4. Comparison of Time-Varying Pattern of Recurrence in Chinese Breast Cancer Patients with Different Molecular Subtypes: A Single-Center Retrospective Study;Oncologie;2022

5. Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL);Cancer Research and Treatment;2021-07-15